Purple Biotech Ltd
PPBT
$3.95
$0.102.55%
NASDAQ
| 12/31/2024 | 12/31/2024 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 35.30% | 35.30% | -14.76% | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | -- | -- | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -82.92% | -82.92% | 34.88% | ||
| Total Current Assets | 28.39% | 28.39% | -11.78% | ||
|
|
|||||
| Total Current Assets | 28.39% | 28.39% | -11.78% | ||
| Net Property, Plant & Equipment | -11.38% | -11.38% | -9.47% | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -- | -- | -- | ||
| Total Assets | 5.51% | 5.51% | -2.66% | ||
|
|
|||||
| Total Accounts Payable | -23.90% | -23.90% | -37.15% | ||
| Total Accrued Expenses | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -0.54% | -0.54% | 1.10% | ||
| Total Finance Division Other Current Liabilities | -65.83% | -65.83% | 206.01% | ||
| Total Other Current Liabilities | -65.83% | -65.83% | 206.01% | ||
| Total Current Liabilities | -26.96% | -26.96% | -15.60% | ||
|
|
|||||
| Total Current Liabilities | -26.96% | -26.96% | -15.60% | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -- | -- | -51.90% | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -0.71% | -0.71% | 0.00% | ||
| Total Liabilities | -26.80% | -26.80% | -15.70% | ||
|
|
|||||
| Common Stock & APIC | 2.77% | 2.77% | 5.94% | ||
| Retained Earnings | -0.28% | -0.28% | -0.46% | ||
| Treasury Stock & Other | -0.42% | -0.42% | -19.53% | ||
| Total Common Equity | 11.73% | 11.73% | 0.32% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | 11.73% | 11.73% | 0.32% | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -8.93% | -8.93% | -8.20% | ||
| Total Equity | 11.69% | 11.69% | 0.31% | ||
|
|
|||||